亿胜生物科技（01061）于2026年8月24日发布公告，披露当日于香港联交所场内回购40,000股普通股，占该次回购前已发行股份（不包括库存股份）的约0.00708%。本次回购每股价格最高为2.28港元、最低为2.25港元，合计耗资约90,600港元。公司确认上述回购股份将被持作库存股份。
本次交易完成后，公司已发行股份（不包括库存股份）数目为565,122,000股，库存股份数目为1,884,000股，合计股份总数为567,006,000股。公告同时提及，公司于2026年5月26日经股东大会批准回购授权，可回购股份的总数上限为56,700,600股。截至该公告披露日，公司根据该回购授权累计已回购1,884,000股，占授权通过当日已发行股份总数的约0.33227%。
公告显示，亿胜生物科技已就上述回购事项严格遵守香港联交所证券上市规则及相关法律法规。公告由公司董事方海洲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.